Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections
Process
RDF description of Development of Sars-CoV-2 MPro protease inhibitors as 'direct-acting antivirals' for the pharmacological treatment of coronavirus infections - http://irises.unimi.it/resource/project/ASS%5FNAZ23ALAI%5F01
Project